Literature DB >> 2193108

Oxidative stress: a role in the pathogenesis of Parkinson's disease.

M E Götz1, A Freyberger, P Riederer.   

Abstract

The degeneration of nigro-striatal dopaminergic neurons is considered to be a predominant pathogenetic factor of Parkinson's disease (PD). However, the etiology of this degeneration is not known. Hypotheses assume accumulation of endogenous and/or exogenous toxins as trigger of the disease. An increase in the concentration of free radicals has been suggested to be toxic to cells, especially when combined with certain metals like free iron or copper. The role of melanin in the degenerative process is not clear, but autoxidative reactions such as the oxidation of dopamine (DA) to melanin generating radicals and toxic metabolites seem to enhance the vulnerability of neurons in the substantia nigra (SN). Disappearance of melanin in the SN, increase of total iron and ferric iron, extreme decrease of glutathione (GSH) levels, reduced activity of enzymes involved in the detoxification of hydrogen peroxide, hydroxyl and superoxide radicals (peroxidases, catalase, glutathione peroxidase), an increase of monoamine oxidase B (MAO B) activity and the substantial increase of malondialdehyde, a marker of lipid peroxidation, in the SN seem to indicate a role of an oxidative stress syndrome in the SN causing or aggravating PD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193108     DOI: 10.1007/978-3-7091-9050-0_23

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  23 in total

1.  Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties.

Authors:  Orly Weinreb; Tamar Amit; Silvia Mandel; Moussa B H Youdim
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

2.  Comparative analysis of four disease prediction models of Parkinson's disease.

Authors:  Nadella Kumudini; Shaik Mohammad Naushad; Balraj Alex Stanley; Manoharan Niveditha; Gunasekaran Sharmila; Konda Kumaraswami; Rupam Borghain; Rukmini Mridula; Vijay Kumar Kutala
Journal:  Mol Cell Biochem       Date:  2015-10-05       Impact factor: 3.396

3.  Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.

Authors:  Santosh Kumar Prajapati; Debapriya Garabadu; Sairam Krishnamurthy
Journal:  Neurotox Res       Date:  2017-01-27       Impact factor: 3.911

4.  Age associated oxidative damage in lymphocytes.

Authors:  Nandeslu Gautam; Subhasis Das; Santanu Kar Mahapatra; Subhankari Prasad Chakraborty; Pratip Kumar Kundu; Somenath Roy
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

Review 5.  Superoxide dismutases: a physiopharmacological update.

Authors:  A Valdivia; S Pérez-Alvarez; J D Aroca-Aguilar; I Ikuta; J Jordán
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

Review 6.  Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

Authors:  T Müller; W Kuhn; H Przuntek
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.

Authors:  Chiaki Isobe; Takashi Abe; Yasuo Terayama
Journal:  J Neurol       Date:  2009-09-27       Impact factor: 4.849

Review 8.  Vitamin E in extrapyramidal disorders.

Authors:  L Bischot; G Van den Brink; A J Porsius
Journal:  Pharm World Sci       Date:  1993-08-20

Review 9.  Treatment of Parkinson's disease.

Authors:  M J Aminoff
Journal:  West J Med       Date:  1994-09

10.  Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone.

Authors:  B N Johnson; B K Yamamoto
Journal:  Neuroscience       Date:  2009-02-03       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.